Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation

被引:0
|
作者
Giabicani, Mikhael [1 ,2 ]
Joly, Pauline [1 ]
Sigaut, Stephanie [1 ]
Timsit, Clara [1 ]
Devauchelle, Pauline [1 ]
Dondero, Federica [5 ]
Durand, Francois [3 ,4 ]
Froissant, Pierre Antoine [1 ]
Lamamri, Myriam [1 ]
Payance, Audrey [3 ,4 ]
Restoux, Aymeric [1 ]
Roux, Olivier [3 ]
Thibault-Sogorb, Tristan [1 ]
Valainathan, Shantha Ram [3 ]
Lesurtel, Mickael [4 ,5 ]
Rautou, Pierre-Emmanuel [3 ,4 ,6 ]
Weiss, Emmanuel [1 ,4 ]
机构
[1] Hop Beaujon, AP HP, DMU Parabol, Dept Anesthesie Reanimat, Clichy, France
[2] Univ Paris Cite, Paris, France
[3] Hop Beaujon, AP HP, Ctr Reference Malad Vasc Foie, Serv Hepatol,DMU DIGEST,FILFOIE,ERN RARE LIVER, Clichy, France
[4] Univ Paris Cite, Ctr Rech Inflammat, UMR 1149, Inserm, Paris, France
[5] Univ Paris Cite, Beaujon Hosp, AP HP, Dept HPB Surg & Liver Transplantat,DMU DIGEST, Clichy, France
[6] Serv Hepatol, Hop Beaujon 100,Blvd Gen Leclerc, F-92110 Clichy, France
关键词
hepatic venous pressure gradient; liver transplantation; bleeding; cirrhosis; portal hypertension; pre-transplant assessment; INTENSIVE-CARE-UNIT; BLOOD-TRANSFUSION; CLINICAL-PRACTICE; REQUIREMENTS; MANAGEMENT; SURVIVAL; SCORE; STAY;
D O I
10.1016/j.jhepr.2024.101051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Major bleeding events during orthotopic liver transplantation (OLT) are associated with poor outcomes. The proportion of this risk related to portal hypertension is unclear. Hepatic venous pressure gradient (HVPG) is the gold standard for estimating portal hypertension. The aim of this study was to analyze the ability of HVPG to predict intraoperative major bleeding events during OLT in patients with cirrhosis. Methods: We retrospectively analyzed a prospective database including all patients with cirrhosis who underwent OLT between 2010 and 2020 and had liver and right heart catheterizations as part of their pre -transplant assessment. The primary endpoint was the occurrence of an intraoperative major bleeding event. Results: The 468 included patients had a median HVPG of 17 mmHg [interquartile range, 13-22] and a median MELD on the day of OLT of 16 [11-24]. Intraoperative red blood cell transfusion was required in 72% of the patients (median 2 units transfused), with a median blood loss of 1,000 ml [575-1,50 0]. Major intraoperative bleeding occurred in 156 patients (33%) and was associated with HVPG, preoperative hemoglobin level, severity of cirrhosis at the time of OLT (MELD score, ascites, encephalopathy), hemostasis impairment (thrombocytopenia, lower fibrinogen levels), and complications of cirrhosis (sepsis, acute -on -chronic liver failure). By multivariable regression analysis with backward elimination, HVPG, preoperative hemoglobin level, MELD score, and tranexamic acid infusion were associated with the primary endpoint. Three categories of patients were identi fied according to HVPG: low -risk (HVPG <16 mmHg), high -risk (HVGP > -16 mmHg), and very high -risk (HVPG > -20 mmHg). Conclusions: HVPG predicted major bleeding events in patients with cirrhosis undergoing OLT. Including HVPG as part of pretransplant assessment might enable better anticipation of the intraoperative course. Impact and implications: Major bleeding events during orthotopic liver transplantation (OLT) are associated with poor outcomes but the proportion of this risk related to portal hypertension is unclear. Our work shows that hepatic venous pressure gradient (HVPG), the gold standard for estimating portal hypertension, is a strong predictor of major bleeding events and blood loss volume in patients with cirrhosis undergoing OLT. Three groups of patients can be identi fied according to their risk of major bleeding events: low -risk patients with HVPG <16 mmHg, high -risk patients with HVPG > -16 mmHg, and very high -risk patients with HVPG > -20 mmHg. HVPG could be systematically included in the pre -transplant assessment to anticipate intraoperative course and tailor patient management. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Increased hepatic venous pressure gradient in patients with cirrhosis and refractory ascites.
    Efrati, C
    Nicolao, F
    Masini, A
    Fiorello, S
    Valeriano, V
    Nicolini, G
    Angeloni, A
    Merli, M
    Riggio, O
    HEPATOLOGY, 2002, 36 (04) : 531A - 531A
  • [42] Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
    Ripoll, Cristina
    Groszmann, Roberto
    Garcia-Tsao, Guadalupe
    Grace, Norman
    Burroughs, Andrew
    Planas, Ramon
    Escorsell, Angels
    Garcia-Pagan, Juan Carlos
    Makuch, Robert
    Patch, David
    Matloff, Daniels.
    Bosch, Jaime
    GASTROENTEROLOGY, 2007, 133 (02) : 481 - 488
  • [43] Measurement of hepatic venous pressure gradient in patients with active variceal bleeding - Reply
    Avgerinos, A
    Vlachogiannakos, J
    Manolakopoulos, S
    Raptis, SA
    HEPATOLOGY, 2005, 41 (02) : 407 - 407
  • [44] HEPATIC VENOUS PRESSURE GRADIENT DOES NOT CORRELATE WITH THE PRESENCE AND THE SEVERITY OF PORTAL HYPERTENSIVE GASTROPATHY IN PATIENTS WITH LIVER CIRRHOSIS
    Lee, Tae-Hee
    Kim, Yong-Suk
    Kim, Sun-Moon
    Im, Euyi-Heog
    Huh, Kyu-Chan
    Choi, Young-Woo
    Kang, Young-Woo
    HEPATOLOGY, 2009, 50 (04) : 474A - 475A
  • [45] Combined Effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis
    Lee, Jae Gon
    Sohn, Joo Hyun
    Jeong, Jae Yoon
    Kim, Tae Yeob
    Kim, Sun Min
    Cho, Young Seo
    Kim, Yongsoo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 401 - 401
  • [46] Acute and 14-Day Hepatic Venous Pressure Gradient Response to Carvedilol and Nebivolol in Patients With Liver Cirrhosis
    Silkauskaite, Vilma
    Kupcinskas, Juozas
    Pranculis, Andrius
    Jonaitis, Laimas
    Petrenkiene, Vitalija
    Kupcinskas, Limas
    MEDICINA-LITHUANIA, 2013, 49 (11): : 467 - 473
  • [47] Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis
    Bellis, Lia
    Nicodemo, Sabino
    Galossi, Alessandra
    Guarisco, Riccardo
    Spilabotti, Lucia
    Durola, Laura
    Dell'Unto, Orlando
    Puoti, Claudio
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2007, 16 (03) : 273 - 277
  • [48] HEPATIC VENOUS PRESSURE GRADIENT DOES NOT CORRELATE WITH THE PRESENCE AND THE SEVERITY OF PORTAL HYPERTENSIVE GASTROPATHY IN PATIENTS WITH LIVER CIRRHOSIS
    Lee, T. -H.
    Kang, Y. -W.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S210 - S210
  • [49] Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis
    Lee, Jae Gon
    Sohn, Joo Hyun
    Jeong, Jae Yoon
    Kim, Tae Yeob
    Kim, Sun Min
    Cho, Young Seo
    Kim, Yongsoo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (01): : 88 - +
  • [50] Predictive value of hepatic venous pressure gradient and efficacy and significance of early PTVE for gastrointestinal bleeding after TACE for liver cancer
    Wei, Jian
    Hu, Yuefeng
    Yu, Jianan
    Yin, Chao
    Chen, Guang
    Jin, Long
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (07) : 1967 - 1972